Clinical Trial Update: ATH-1017 Treatment in Subjects With Parkinson's Disease Dementia or Dementia With Lewy Bodies (SHAPE Trial) [Phase 2]

View source ↗

Summary

The SHAPE Phase 2 trial evaluating ATH-1017 in Parkinson disease dementia and dementia with Lewy bodies was terminated, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia with Lewy Bodies
• Parkinson Disease Dementia

Drugs mentioned

• ATH-1017

Snippet

Sponsor: LeonaBio | Conditions: Parkinson Disease Dementia, Dementia With Lewy Bodies | Phase 2 | Status: TERMINATED | Results posted: 2025-03-04